MYALEPTA 11.3 mg, powder for solution for injection bottle, 5 ml
Active ingredients: Metreleptin
Commercialized according to BDPMDispensing in France: Prescription only
Powder for solution for injectionbottle, 5 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MYALEPTA 11,3 mg, poudre pour solution injectable
- Pharmaceutical form
- poudre pour solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 1 flacon en verre de 5 mL
- Marketing authorisation holder
- CHIESI FARMACEUTICI
- Reimbursement according to BDPM
- 100 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Jul 2019
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Initial prescription by a specialist
- Renewal by a specialist only
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
69994784CIP73015093CIP133400930150931Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MÉTRÉLEPTINEpoudre | 11,3 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.